New Movement to End Disparities in Clinical Trials Launched | When We Tri(al)
TOUCH, the Black Breast Cancer Alliance and Breastcancer.org announced the launch of When We Tri(al), a movement dedicated to empowering and educating Black women on the importance of clinical trial participation. The movement aims to change the devastating breast cancer mortality rates for Black women, who are 41% more likely to die from breast cancer than white women.
The When We Tri(al) movement launched on Wednesday, January 26, 2022, with an empowering event featuring leading voices in the medical field and the Black breast cancer community.
Black women are drastically underrepresented in clinical trials; only 3% of clinical trial participants leading to FDA approval of cancer drugs between 2008 and 2018 were Black. The consequences are dire: too many Black women are missing out on access to newly emerging and often life-extending treatments. Until more Black women are included in the research, they will continue to face worse breast cancer outcomes. When We Tri(al) is focused on the urgent need to end these disparities.
Learn more about When We Tri(al) below.
read the Fierce Pharma article
read the Black Enterprise article
